SA Transcripts • Aug. 2, 2013
There are no Focus articles on KMDA.
We currently have no Breaking News on this stock.
There are no StockTalks on this stock yet.
KMDA vs. ETF Alternatives
Kamada Ltd is an orphan drug, plasma-derived protein therapeutics company and develops and produces specialty plasma-derived protein therapeutics. Its product candidates include Glassia and Inhaled Alpha-1 Antitrypsin for its deficiency.
Other News & PR